167 related articles for article (PubMed ID: 3516484)
1. Overview of the clinical relevance of autologous bone marrow transplantation.
Appelbaum FR; Buckner CD
Clin Haematol; 1986 Feb; 15(1):1-18. PubMed ID: 3516484
[No Abstract] [Full Text] [Related]
2. Clinical studies of autologous bone marrow transplantation in Hodgkin's disease.
Phillips GL; Reece DE
Clin Haematol; 1986 Feb; 15(1):151-66. PubMed ID: 3516487
[TBL] [Abstract][Full Text] [Related]
3. Current status of syngeneic marrow transplantation and its relevance to autografting.
Fefer A
Clin Haematol; 1986 Feb; 15(1):49-65. PubMed ID: 3516493
[No Abstract] [Full Text] [Related]
4. Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.
Schütt P; Passon J; Ebeling P; Welt A; Müller S; Metz K; Moritz T; Seeber S; Nowrousian MR
Eur J Haematol; 2007 Feb; 78(2):93-101. PubMed ID: 17313557
[TBL] [Abstract][Full Text] [Related]
5. Modified chemotherapy with carmustine, cytarabine, cyclophosphamide, and 6-thioguanine (BACT) and autologous bone marrow transplantation in 24 poor-risk patients with acute lymphoblastic leukemia.
Pico JL; Hartmann O; Maraninchi D; Beaujean F; Benhamou E; Mascret B; Novakovitch G; Ghalie R; Kalifa C; Hayat M
J Natl Cancer Inst; 1986 Jun; 76(6):1289-93. PubMed ID: 3520070
[TBL] [Abstract][Full Text] [Related]
6. High-dose cyclophosphamide, carmustine, and etoposide followed by allogeneic bone marrow transplantation in patients with lymphoid malignancies who had received prior dose-limiting radiation therapy.
Demirer T; Weaver CH; Buckner CD; Petersen FB; Bensinger WI; Sanders J; Clift RA; Lilleby K; Anasetti C; Martin P
J Clin Oncol; 1995 Mar; 13(3):596-602. PubMed ID: 7884421
[TBL] [Abstract][Full Text] [Related]
7. Autologous bone marrow transplantation in haematologic malignancies.
Marmont AM; Carella AM
Haematologica; 1986; 71(1):1-12. PubMed ID: 3084348
[No Abstract] [Full Text] [Related]
8. Favorable outcome of patients with relapsed or refractory Hodgkin's disease treated with high-dose chemotherapy and stem cell rescue at the time of maximal response to conventional salvage therapy (Dex-BEAM).
Josting A; Kàtay I; Rueffer U; Winter S; Tesch H; Engert A; Diehl V; Wickramanayake PD
Ann Oncol; 1998 Mar; 9(3):289-95. PubMed ID: 9602263
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the use of high-dose cytoreduction with autologous marrow rescue in various malignancies.
Dicke KA; Spitzer G
Transplantation; 1986 Jan; 41(1):4-20. PubMed ID: 3001980
[No Abstract] [Full Text] [Related]
10. High-dose chemotherapy and autologous bone marrow transplantation for relapsed and refractory Hodgkin's disease.
Harding M; Selby P; Gore M; Perren T; Treleavan J; Mansi J; Zulian G; Milan S; Meldrum M; Viner C
Eur J Cancer; 1992; 28A(8-9):1396-400. PubMed ID: 1515256
[TBL] [Abstract][Full Text] [Related]
11. Very high dose chemotherapy with autologous bone marrow rescue in adult patients with resistant relapsed lymphoma.
Anderson CC; Goldstone AH; Souhami RL; Linch DC; Harper PG; McLennan KA; Jones M; Machin SJ; Jelliffe AM; Cawley JC
Cancer Chemother Pharmacol; 1986; 16(2):170-5. PubMed ID: 3512114
[TBL] [Abstract][Full Text] [Related]
12. Perspectives for the use of high-dose chemotherapy in the treatment of solid malignant tumors.
Sculier JP; Klastersky J
Eur J Cancer Clin Oncol; 1984 Nov; 20(11):1335-7. PubMed ID: 6389145
[No Abstract] [Full Text] [Related]
13. [Treatment strategy of Hodgkin lymphoma].
Nagai H
Rinsho Ketsueki; 2014 Oct; 55(10):1941-51. PubMed ID: 25297759
[No Abstract] [Full Text] [Related]
14. Intensive therapy and autotransplantation in Hodgkin's disease.
Reece DE; Phillips GL
Stem Cells; 1994 Sep; 12(5):477-93. PubMed ID: 7804123
[TBL] [Abstract][Full Text] [Related]
15. Factors influencing prognosis after dose-intensive therapy for recurrent or refractory Hodgkin's disease. Results of sequential trials: a case for treating patients with resistant disease.
Ahmed T; Lake D; Feldman E; Seiter K; Helson L; Mittelman A; Puccio C; Chun H; Grima K; Akhtar T
Ann N Y Acad Sci; 1995 Dec; 770():305-14. PubMed ID: 8597368
[No Abstract] [Full Text] [Related]
16. A randomized trial of chemotherapy with carmustine, etoposide, cytarabine, and melphalan (BEAM) plus peripheral stem cell transplantation (PBSCT) vs single-agent high-dose chemotherapy followed by BEAM plus PBSCT in patients with relapsed Hodgkin's disease (HD-R2).
Glossmann JP; Josting A; Pfistner B; Paulus U; Engert A;
Ann Hematol; 2002 Aug; 81(8):424-9. PubMed ID: 12223998
[No Abstract] [Full Text] [Related]
17. Treatment of relapsed and refractory Hodgkin's disease with high dose chemotherapy and autologous bone marrow transplantation.
Brice P; Gisselbrecht C; Ferme C; Lepage E; Baruchel A; Marolleau JP; Gerota O; Boiron M
Nouv Rev Fr Hematol (1978); 1991; 33(3):267-72. PubMed ID: 1956765
[TBL] [Abstract][Full Text] [Related]
18. Impressive response to pegylated liposomal doxorubicin after allogeneic transplantation in a multi-relapsed Hodgkin's lymphoma.
Pellegrini C; Maglie R; Argnani L; Pileri S; Zinzani PL
Hematol Oncol; 2016 Mar; 34(1):49-51. PubMed ID: 25243375
[No Abstract] [Full Text] [Related]
19. BEAC (carmustine, etoposide, cytarabine, and cyclophosphamide) in autologous hematopoietic cell transplantation: a safe and effective alternative conditioning regimen for Hodgkin and non-Hodgkin lymphoma.
Sakellari I; Gavriilaki E; Bouziana S; Constantinou V; Mallouri D; Vardi A; Marvaki A; Batsis I; Sotiropoulos D; Anagnostopoulos A
Bone Marrow Transplant; 2019 Jun; 54(6):921-923. PubMed ID: 30410083
[No Abstract] [Full Text] [Related]
20. High-dose therapy and autologous stem cell transplantation for Hodgkin's lymphoma in relapse or failure after initial chemotherapy : results of the Centre National de Greffe de Moelle Osseuse de Tunis.
Torjman L; Ladeb S; Lakhal A; Ben Othman T; Abdelkefi A; Ben Abdeladhim A
Tunis Med; 2007 Jan; 85(1):35-8. PubMed ID: 17424707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
